{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:30:40Z","timestamp":1783402240984,"version":"3.54.6"},"reference-count":33,"publisher":"SLACK, Inc.","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Ann"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:sec>\n            <jats:title>CME Educational Objectives<\/jats:title>\n            <jats:list list-type=\"order\">\n              <jats:list-item>\n                <jats:label>1.<\/jats:label>\n                <jats:p>Understand that trivalent influenza vaccine is safe for patients with egg allergy, including patients with severe egg allergy.<\/jats:p>\n              <\/jats:list-item>\n              <jats:list-item>\n                <jats:label>2.<\/jats:label>\n                <jats:p>Understand that egg-allergic patients no longer require any special precautions to safely receive trivalent influenza vaccine.<\/jats:p>\n              <\/jats:list-item>\n              <jats:list-item>\n                <jats:label>3.<\/jats:label>\n                <jats:p>Recognize that the Centers for Disease Control and Prevention\u2019s Advisory Committee on Immunization Practices advises that most egg-allergic patients can now receive trivalent influenza vaccine from their primary care physician.<\/jats:p>\n              <\/jats:list-item>\n            <\/jats:list>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>Trivalent influenza vaccine is grown in chick embryos and contains residual egg protein (ovalbumin). Historically, trivalent influenza vaccine (TIV) has been contraindicated in egg-allergic individuals (EAI) and the vaccine was withheld in many of these individuals due to the ovalbumin. However, protocols were developed that allowed EAIs to safely receive TIV, including stepwise desensitization, vaccine skin testing, and use of low ovalbumin containing vaccine. In the past 3 years, several groups have systematically disproven that EAI are at any increased risk for an allergic reaction than the general population and withholding TIV is not necessary. To date, approximately 4,315 patients have safely received 4,872 total doses of TIV, including 656 EAI with severe egg allergy (including anaphylaxis to egg) who safely received 740 doses of TIV. Thus, it is as safe to provide TIV to EAI as providing it to a non-EAI. This article will trace the evolution of this practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/00904481-20130619-09","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T14:51:09Z","timestamp":1372344669000},"source":"Crossref","is-referenced-by-count":3,"title":["Establishing the Safety of Influenza Vaccine in Egg-Allergic Individuals"],"prefix":"10.3928","volume":"42","author":[{"given":"Matthew J.","family":"Greenhawt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/am.21.4.780-782.1971"},{"key":"e_1_3_1_3_2","first-page":"400","volume-title":"Red Book: 2009 Report of the Committtee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2009","unstructured":"American Academy of Pediatrics. Influenza. In: Pickering LK, Kimberlin DW, Long SS (eds). Red Book: 2009 Report of the Committtee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:400\u2013412.","edition":"28"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.129372"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2010.11.015"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70101-5"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.05.037"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-2512"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2011.01.024"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.10.005"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.02.013"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.11.038"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.046"},{"issue":"4","key":"e_1_3_1_14_2","first-page":"31","article-title":"The future of sublingual immunotherapy","volume":"22","author":"Marcucci F","year":"2009","unstructured":"Marcucci F, Duse M, Frati F, Incorvaia C, Marseglia GL, La Rosa M. The future of sublingual immunotherapy. Int J Immunopathol Pharmacol. 2009;22(Suppl 4):31\u201333.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.04.003"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2012.09.011"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.11.1333"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-0204"},{"issue":"6","key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.10.008","article-title":"Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel","volume":"126","author":"Boyce JA","year":"2010","unstructured":"Boyce JA, Assa\u2019ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(6 Suppl):S1\u201358.","journal-title":"J Allergy Clin Immunol"},{"issue":"47","key":"e_1_3_1_20_2","first-page":"461","article-title":"Vaccines against influenza WHO position paper","volume":"87","year":"2012","unstructured":"Vaccines against influenza WHO position paper. Wkly Epidemiol Rec. 2012;87(47):461\u2013476.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_1_21_2","first-page":"CD000364","article-title":"Vaccines for preventing influenza in people with asthma","volume":"2","author":"Cates CJ","year":"2013","unstructured":"Cates CJ, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev. 2013;2:CD000364.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1946.02870500005002"},{"issue":"1","key":"e_1_3_1_23_2","first-page":"254","article-title":"Allergenic and anaphylactogenic properties of vaccines prepared from embryonic tissues of developing chicks; a study to determine whether chick yolk sac vaccines contained sufficient egg proteins to cause severe systemic reactions if given to egg-sensitive individuals","volume":"5","author":"Stull A","year":"1946","unstructured":"Stull A. Allergenic and anaphylactogenic properties of vaccines prepared from embryonic tissues of developing chicks; a study to determine whether chick yolk sac vaccines contained sufficient egg proteins to cause severe systemic reactions if given to egg-sensitive individuals. Fed Proc. 1946;5(1 Pt 2):254.","journal-title":"Fed Proc"},{"issue":"5","key":"e_1_3_1_24_2","first-page":"608","article-title":"Allergy to viral and rickettsial vaccines. II. Allergic reactions encountered and further studies with refined influenza and mumps vaccines in allergic children","volume":"83","author":"Ratner B","year":"1952","unstructured":"Ratner B, Untracht S, Hertzmark F. Allergy to viral and rickettsial vaccines. II. Allergic reactions encountered and further studies with refined influenza and mumps vaccines in allergic children. Am J Dis Child. 1952;83(5):608\u2013617.","journal-title":"Am J Dis Child"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112896"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/136.Supplement_3.S652"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-0539"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(76)90095-6"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.019"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2010.08.015"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.03.009"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.12.015"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.09.040"},{"key":"e_1_3_1_34_2","first-page":"613","article-title":"Prevention and control of influenza with vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) \u2014 United States, 2012\u201313 Influenza Season","volume":"61","author":"Grohskopf L","year":"2012","unstructured":"Grohskopf L, Uyeki T, Breesee J, Cox N. Prevention and control of influenza with vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) \u2014 United States, 2012\u201313 Influenza Season. Morb Mortal Wkly Rep MMWR. 2012;61:613\u2013618.","journal-title":"Morb Mortal Wkly Rep MMWR"}],"container-title":["Pediatric Annals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/00904481-20130619-09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T23:20:59Z","timestamp":1683069659000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/00904481-20130619-09"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.3928\/00904481-20130619-09"],"URL":"https:\/\/doi.org\/10.3928\/00904481-20130619-09","relation":{},"ISSN":["0090-4481","1938-2359"],"issn-type":[{"value":"0090-4481","type":"print"},{"value":"1938-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}